Gritstone bio, Inc. is a biotechnology company that develops immunotherapies for various cancer types and infectious diseases. The company's lead product candidate, GRANITE, is an immunotherapy for the treatment of solid tumors. It also develops SLATE, CORAL, and a therapeutic vaccine candidate, and has collaborations with bluebird bio and Gilead Sciences.